haloprogin has been researched along with Melanoma in 1 studies
haloprogin: minor descriptor (73-86); on-line & INDEX MEDICUS search PHENYL ETHERS (73-86)
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The combination with the repurposed chemodrug haloprogin provides the basis for a new powerful treatment option for cutaneous melanoma." | 1.48 | Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment. ( Demaria, O; Dyson, PJ; Gilliet, M; Joncic, A; Riedel, T; Zava, O, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riedel, T | 1 |
| Demaria, O | 1 |
| Zava, O | 1 |
| Joncic, A | 1 |
| Gilliet, M | 1 |
| Dyson, PJ | 1 |
1 other study available for haloprogin and Melanoma
| Article | Year |
|---|---|
Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Cell Survival; Drug Repositioning; Drug Synergism | 2018 |